Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
REVIEW
Vassili Panagides, Jules Mesnier, Jorge Nuche, Robert Delarochellière, Jean-Michel Paradis, Dimitri Kalavrouziotis, Eric Dumont, Siamak Mohammadi, Josep Rodes-Cabau
INTRODUCTION: Since the initial experience with the CoreValve (Medtronic, Minneapolis, Minnesota), there have been continuous iterations of this valve system in order to improve procedural success and reduce periprocedural complications. The Evolut Pro, Pro+, and FX are the latest generations of this transcatheter heart valve (THV). AREAS COVERED: This review paper aims to analyze the main characteristics and clinical evidence about the Evolut Pro THV and summarize the main iterations of the newer generation Evolut FX valve system...
July 2022: Expert Review of Medical Devices
#22
JOURNAL ARTICLE
Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, Shinichi Shirai, Takeshi Kitai, Hiroyuki Tabata, Kazuki Kitano, Nobuhisa Ono, Ryosuke Murai, Kohei Osakada, Koichiro Murata, Masanao Nakai, Hiroshi Tsuneyoshi, Tomohisa Tada, Masashi Amano, Hiroki Shiomi, Hirotoshi Watanabe, Yusuke Yoshikawa, Ko Yamamoto, Mamoru Toyofuku, Shojiro Tatsushima, Norino Kanamori, Makoto Miyake, Hiroyuki Nakayama, Kazuya Nagao, Masayasu Izuhara, Kenji Nakatsuma, Moriaki Inoko, Takanari Fujita, Masahiro Kimura, Mitsuru Ishii, Shunsuke Usami, Kenichiro Sawada, Fumiko Nakazeki, Marie Okabayashi, Manabu Shirotani, Yasutaka Inuzuka, Tatsuhiko Komiya, Kenji Minatoya, Takeshi Kimura
BACKGROUND: There is scarce data evaluating the current practice pattern and clinical outcomes for patients with severe aortic stenosis (AS), including both those who underwent surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) and those who were managed conservatively in the TAVI era.Methods and Results: The Contemporary outcomes after sURgery and medical tREatmeNT in patients with severe Aortic Stenosis (CURRENT AS) Registry-2 is a prospective, physician-initiated, multicenter registry enrolling consecutive patients who were diagnosed with severe AS between April 2018 and December 2020 among 21 centers in Japan...
April 19, 2022: Circulation Journal: Official Journal of the Japanese Circulation Society
#23
JOURNAL ARTICLE
Mariusz Kowalewski, Michał Pasierski, Janina Finke, Michalina Kołodziejczak, Jakub Staromłyński, Radosław Litwinowicz, Grzegorz Filip, Adam Kowalówka, Wojciech Wańha, Przemysław Bławat, Andrzej Łoś, Sebastian Stefaniak, Wojciech Wojakowski, Marek Jemielity, Jan Rogowski, Marek Deja, Dariusz Jagielak, Krzysztof Bartus, Katarzyna Sierakowska, Silvia Mariani, Tong Li, Justine Mafalda Ravaux, Matteo Matteucci, Daniele Ronco, Federica Jiritano, Dario Fina, Gennaro Martucci, Paolo Meani, Giuseppe Maria Raffa, Pietro Giorgio Malvindi, Roberto Lorusso, Piotr Suwalski
BACKGROUND: Among patients referred for cardiac surgery, atrial fibrillation (AF) is a common comorbidity and a risk factor for postoperative arrhythmias (eg, sinus node dysfunction, atrioventricular heart block), including those requiring permanent pacemaker (PPM) implantation. OBJECTIVE: The purpose of this study was to evaluate the prevalence and long-term survival of postoperative PPM implantation in patients with preoperative AF who underwent valve surgery with or without concomitant procedures...
September 2022: Heart Rhythm: the Official Journal of the Heart Rhythm Society
#24
JOURNAL ARTICLE
Guglielmo Gallone, Alessandro Depaoli, Fabrizio D'Ascenzo, Davide Tore, Luca Allois, Francesco Bruno, Maurizio Casale, Francesco Atzeni, Giulia De Lio, Pier Paolo Bocchino, Francesco Piroli, Filippo Angelini, Andrea Angelini, Luca Scudeler, Francesca De Lio, Alessandro Andreis, Stefano Salizzoni, Michele La Torre, Federico Conrotto, Mauro Rinaldi, Paolo Fonio, Gaetano M De Ferrari
BACKGROUND: The adoption of Computed tomography (CT)-defined sarcopenia to risk stratify transcatheter aortic valve implantation (TAVI) candidates remains limited by a lack of both standardized definition and evidence of independent value over currently adopted mortality prediction tools. METHODS: 391 consecutive TAVI patients with pre-procedural CT scan were included (81 ± 6 years, 57.5% male, STS-PROM score 4.4 ± 3.6%) and abdominal muscle retrospectively quantified...
May 2022: Journal of Cardiovascular Computed Tomography
#25
JOURNAL ARTICLE
Andra Oancea, Cristina Furnică, Raluca Ozana Chistol, Florin Mitu, Maria-Magdalena Leon-Constantin, Grigore Tinică
(1) Background: The aging process leads to an increased number of patients with cardiovascular diseases that require surgical treatment. One of the most common heart diseases with an increased prevalence in the elderly is aortic stenosis (AS). Recently, transcatheter aortic valve implantation (TAVI) has become the preferred technique for frail patients with high surgical risk. Currently, there is no gold standard method for assessing frailty. The available scores are objective, but limited by the lack of prospective information, especially from patients undergoing cardiac surgery or interventional procedures...
October 10, 2021: Diagnostics
#26
REVIEW
Maximilian A Fliegner, Devraj Sukul, Michael P Thompson, Nirav J Shah, Reza Soroushmehr, Jeffrey S McCullough, Donald S Likosky
BACKGROUND: Aortic stenosis is a prevalent valvular heart disease that is treated primarily by surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR), which are common treatments for addressing symptoms secondary to valvular heart disease. This narrative review article focuses on the existing literature comparing recovery and cost-effectiveness for SAVR and TAVR. METHODS: Major databases were searched for relevant literature discussing HRQOL and cost-effectiveness of TAVR and SAVR...
October 2021: IJC Heart & Vasculature
#27
JOURNAL ARTICLE
Yihua Liu, Mohamed-Yassine Benzha, Maxime Hubert, Benjamin Perin, Giuseppe Lauria, Pan Dan, Elodie Phamisith, Soukaina Scadi, Nianguo Dong, Jean-Pierre Villemot, Juan-Pablo Maureira
BACKGROUND: Valve-sparing aortic root replacement (VSRR) techniques have several advantages such as preservation of physiological haemodynamics of the native aortic valve and avoidance of prosthetic valve-related complications. However, VSRR procedures are generally performed in young patients and the long-term results in elderly patients (≥65 years) are scarce. METHODS: Fifty-six (56) consecutive patients underwent VSRR surgery by a single surgeon at the current centre between January 2006 and December 2013; a modified "remodelling technique" was typically performed...
August 28, 2021: Heart, Lung & Circulation
#28
JOURNAL ARTICLE
Benjamin Löser, Annika Haas, Amelie Zitzmann, Andre Dankert, Sascha Treskatsch, Daniel A Reuter, Sebastian Haas, Änne Glass, Martin Petzoldt
OBJECTIVES: Transfemoral transcatheter aortic valve implantation (TF-TAVI) is an established therapy for patients with symptomatic aortic stenosis, which requires periprocedural anaesthesia care. In 2015, the German Federal Joint Committee released a directive on minimally invasive heart valve interventions which defines institutional infrastructural requirements in German heart centres. But still generally accepted expert consensus recommendations or national or international guidelines regarding periprocedural anaesthesia management for TF-TAVI are lacking...
August 4, 2021: BMJ Open
#29
MULTICENTER STUDY
Yahya Dadjo, Maryam Moshkani Farahani, Reza Nowshad, Mohsen Sadeghi Ghahrodi, Alireza Moaref, Javad Kojuri
BACKGROUND: Rheumatic heart disease (RHD) is still a concerning issue in developing countries. Among delayed RHD presentations, rheumatic mitral valve stenosis (MS) remains a prevalent finding. Percutaneous transvenous mitral commissurotomy (PTMC) is the intervention of choice for severe mitral stenosis (MS). We aimed to assess the mid-term outcome of PTMC in patients with immediate success. METHODS: In this retrospective cohort study, out of 220 patients who had undergone successful PTMC between 2006 and 2018, the clinical course of 186 patients could be successfully followed...
July 28, 2021: BMC Cardiovascular Disorders
#30
Najma Latif, Ahmed Mahgoub, Mohamed Nagy, Padmini Sarathchandra, Magdi H Yacoub
Background. The pulmonary autograft is currently the best valve substitute in terms of longevity and performance. However, there is no agreement about the optimal method of insertion (sub-coronary position or freestanding root). Objectives. We sought to examine the clinical status, detailed imaging and morphometric changes in an explanted pulmonary autograft 22 years after sub-coronary implantation. Methods. A 30-year-old female underwent pulmonary autograft replacement of a severely stenotic valve at the age of 7 years, after presenting to us with signs of moderate to severe heart failure...
June 30, 2021: Global Cardiology Science & Practice
#31
REVIEW
Vassili Panagides, Alberto Alperi, Jules Mesnier, Francois Philippon, Mathieu Bernier, Josep Rodes-Cabau
Introduction : Over the past decade, the number of transcatheter aortic valve replacement (TAVR) procedures has increased exponentially. Despite major improvements in both device and successes, the rate of hospital readmission after TAVR remains high, with heart failure (HF) decompensation being one of the most important causes. Areas covered : This review provides an overview of the current status of HF following TAVR, including details about its incidence, clinical impact, contributing factors, and current and future treatment perspectives...
August 2021: Expert Review of Cardiovascular Therapy
#32
REVIEW
Elias Rawish, Tobias Schmidt, Ingo Eitel, Christian Frerker
PURPOSE OF REVIEW: Transcatheter mitral valve replacement (TMVR) has been developed to address the need for an alternative therapeutic option to surgery in patients suffering from severe mitral regurgitation who are at high surgical risk. The present review illustrated the state-of-the-art of catheter-based mitral valve replacement evaluating technical characteristics and early clinical experience of different devices to outline prospects and challenges of TMVR. RECENT FINDINGS: Several devices are currently under clinical assessment...
July 1, 2021: Current Cardiology Reports
#33
JOURNAL ARTICLE
Jiameng Ren, Yanmin Yang, Jun Zhu, Shuang Wu, Juan Wang, Han Zhang, Xinghui Shao
Introduction: There were few data about the clinical profiles and long-term outcomes in Chinese patients with atrial fibrillation (AF) and bioprosthetic valves. Methods: The retrospective study enrolled 903 patients with bioprosthetic valve replacement at our hospital and discharged with a diagnosis of AF from January 2010 to December 2018. Results: The median age was 65.6 (61.9-69.1) years, and 548 (60.7%) patients were women. During a follow-up period of 3.84 (2.64-5.51) years, 68 (1.8 per 100 person-years) patients died, 81 (2...
2021: Frontiers in Cardiovascular Medicine
#34
REVIEW
Alberto Alperi, Juan F Granada, Mathieu Bernier, François Dagenais, Josep Rodés-Cabau
Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left untreated, it confers a poorer prognosis. Catheter-based repair therapies face some limitations like their applicability on challenging anatomies and the potential recurrence of significant MR over time. Transcatheter mitral valve replacement (TMVR) has emerged as a less invasive approach potentially overcoming some of the current limitations associated with transcatheter mitral valve repair. Several devices are under clinical investigation, and a growing number of systems allow for a fully percutaneous transfemoral approach...
June 22, 2021: Journal of the American College of Cardiology
#35
REVIEW
Roland Hetzer, Mariano Francisco Del Maria Javier, Frank Wagner, Matthias Loebe, Eva Maria Javier Delmo
Over time, various surgical treatment strategies have evolved to manage advanced heart failure (HF). Scientific and technological breakthroughs through the last 50 years have put forward various surgical alternatives to patients with advanced HF encompassing surgical ventricular restoration to surgical gene therapy and stem cell replacement of the diseased ventricles. Organ-saving surgical options which used to be promising included dynamic cardiomyoplasty, partial resection of ventricle and cardiac wrapping with Acorn CorCap cardiac support device...
February 2021: Cardiovascular Diagnosis and Therapy
#36
JOURNAL ARTICLE
Christian Nitsche, Andreas A Kammerlander, Matthias Koschutnik, Leah Sinnhuber, Nabila Forutan, Anna Eidenberger, Carolina Donà, Florian Schartmueller, Varius Dannenberg, Max-Paul Winter, Jolanta Siller-Matula, Anahit Anvari-Pirsch, Georg Goliasch, Christian Hengstenberg, Julia Mascherbauer
AIMS: Fluid overload (FO) puts aortic stenosis (AS) patients at risk for heart failure (HF) and death. However, conventional FO assessment, including rapid weight gain, peripheral oedema, or chest radiography, is inaccurate. Bioelectrical impedance spectroscopy (BIS) allows objective and reproducible FO quantification, particularly if clinically unapparent. It is used in dialysis patients to establish dry weight goals. BIS has not been tested for prognostication in AS. This study aimed to evaluate whether BIS adds prognostic information in stable patients undergoing transcatheter aortic valve replacement (TAVR)...
February 13, 2021: ESC Heart Failure
#37
JOURNAL ARTICLE
Anja Fog Heen, Lyubov Lytvyn, Michael Shapiro, Gordon Henry Guyatt, Reed Alexander Cunningham Siemieniuk, Yuan Zhang, Veena Manja, Per Olav Vandvik, Thomas Agoritsas
The review aims to summarise evidence addressing patients' values, preferences and practical issues on deciding between transcatheter aortic valve insertion (TAVI) and surgical aortic valve replacement (SAVR) for aortic stenosis. We searched databases and grey literature until June 2020. We included studies of adults with aortic stenosis eliciting values and preferences about treatment, excluding medical management or palliative care. Qualitative findings were synthesised using thematic analysis, and quantitative findings were narratively described...
August 2021: Heart
#38
Kaishi Otsuka, Hiroaki Kawano, Takashi Ishimatsu, Tsuyoshi Yoshimuta, Yoshiyuki Doi, Satoki Fukae, Seiji Koga, Satoshi Ikeda, Kiyoyuki Eishi, Koji Maemura
A 59-year-old Japanese woman was admitted with heart failure due to severe pulmonary regurgitation and tricuspid regurgitation, in addition to atrial fibrillation 45 years after surgical correction of tetralogy of Fallot (TOF). She had been under treatment with medication and catheter ablation for arrhythmia including ventricular tachycardia for the past 28 years. She underwent pulmonary valve replacement as well as tricuspid and mitral valvuloplasty, which obviously improved her status even though her right ventricular end-diastolic volume index exceeded the recommended threshold...
February 2021: Journal of Cardiology Cases
#39
REVIEW
Guillem Muntané-Carol, Alberto Alperi, Laurent Faroux, Elisabeth Bédard, François Philippon, François Dagenais, Josep Rodés-Cabau
Tricuspid valve disease, and particularly the management of severe tricuspid regurgitation (TR), has gained momentum in recent years. Although it is well known that this frequent condition is associated with poor clinical outcomes, these patients have been classically managed medically, leading to end-stage right ventricular heart failure. Moreover, late referral to surgery has contributed to a high rate of periprocedural complications and in-hospital surgical mortality. Thus, the development of a less invasive catheter-based therapy would be of high clinical relevance in this context...
July 2021: Canadian Journal of Cardiology
#40
JOURNAL ARTICLE
Yan Chen, Junjie Hu, Shunqiang Wu, San Zhang, Kaiqin Wu, Wenli Wang, Yongxin Zhou
Transcatheter mitral valve replacement is increasingly being used as a treatment for high-risk patients who have native mitral valve disease; however, no comprehensive studies on its effectiveness have been reported. We therefore searched the literature for reports on patients with native mitral valve disease who underwent transcatheter access treatment. We found 40 reports, published from September 2013 through April 2017, that described the cases of 66 patients (mean age, 71 ± 12 yr; 30 women; 30 patients with mitral stenosis, 34 with mitral regurgitation, and 2 mixed) who underwent transcatheter mitral valve replacement...
August 1, 2020: Texas Heart Institute Journal
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
